Background:Preeclampsia isthe most significant reason of maternal mortality throughout the world, as well asgolden way to perinatal mortality and morbidity, affecting 2–8% of pregnancies.Objective:To see how magnesium sulfate affects fetal umbilical artery Doppler changesin women suffering from extreme preeclampsia.Methods: It is interventional (experimental) non-randomized study wascarried out in the department of gynecology of the al-hussein university hospital according to sample size.50 women in this study weredrawn from the emergency department and the Obstetrics outpatient clinic. Between April 2020 and January 2021, they were all diagnosed with extreme preeclampsia.Results:The treatment of magnesium sulfate to pregnant women having serious preeclampsia and eclampsiaminimize umbilical artery Doppler velocimetry indices by a statistically significant amount. In terms of different Doppler parameters, there was a considerable difference in the study group's umbilical artery Doppler parameters before and after magnesium sulfate treatment (mean values of Resistance Index, PulsatilityIndex, and Systolic/Diastolic ratio in the study group).
The conclusion:to diagnose complications and evaluate fetal well-being in pregnant women suffering preeclampsia, clinical examinations should be backed up and verified by laboratory tests and ultrasonography. Doppler flow tests should be included in the sonographic review since they can help predict preeclampsia and determine fetal condition.